The information provided herein is generated by experimental artificial intelligence and is for informational purposes only.
rising allergy prevalence drives demand for epinephrine auto-injectors and innovations
A global strategy consulting firm is poised to enhance competitive advantages in the healthcare sector through innovative technological solutions and advanced analytics. The regenerative medicine market is projected to grow from USD 20.09 billion in 2024 to USD 139.70 billion by 2034, while the pharmaceutical market is expected to nearly double from USD 1,573.20 billion in 2023 to USD 3,033.21 billion by 2034. Recent FDA approvals, including a new epinephrine injection, highlight ongoing advancements in medical treatments.